Clinical and Translational Discovery (Sep 2022)
Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway
Abstract
No abstracts available.